Traditional stainless steel cannulas limit delivery of therapeutic along a straight trajectory. Multiple penetrations of brain tissue are needed to achieve three-dimensional distribution, leading to sub-optimal precision and unnecessary trauma.
Atanse’s radial microcannula technology permits three-dimensional dissemination of therapeutic from a single penetration of brain tissue. The Intracerebral Microinjection Instrument (IMI) is a therapeutic delivery device that is designed to provide neurosurgeons with improved control and precision, reduction in trauma and morbidity, and improved treatment efficacy.
Atanse values collaborations and partnerships with other companies and institutions to promote innovative intracerebral drug delivery. For more information about partnership opportunities, please send us a brief message describing the challenge that you are seeking to solve.
Mr. Kelly is an experienced engineer and entrepreneur, having bought and integrated seven companies and sold five. He has a BS/MS from the Massachusetts Institute of Technology and an MBA from Harvard University.
Dr. Cunningham is the inventor of Atanse's core technology. He is the Director of the Laboratory for Neural Reconstruction at McLean Hospital and is affiliated with Harvard University Medical School. He has an MD from Harvard University and a PhD from the Massachusetts Institute of Technology.
Mr. Leonard founded a previous medical device company and has experience in project management, foundation relations, and communications. He has a BS in Neuroscience from Brown University and is pursuing an MS in Engineering Management at Tufts University.
68 Leonard Street, 3rd Floor
Belmont, MA 02478
To request additional information about Atanse, please contact us using the form below.